ArborMetrix provides real-time, risk-adjusted clinical performance analytics tools that enable healthcare providers and payers to improve the quality and effectiveness of surgical and other acute hospital and specialty-based care. The company is led by CEO Brett Furst and is based in Ann Arbor, Mich. In October 2014 it raised an additional $1.3M as part of its Series B financing. The new capital is intended to accelerate the company’s national market expansion. Prior to this close, the first close of the Series B was announced in July 2013 and was led by RPM Ventures with participation from Arboretum Ventures and Wolverine Venture Fund. No operating metrics or total round size beyond the additional $1.3M were disclosed in the article. ArborMetrix provides real-time, risk-adjusted clinical performance analytics tools for hospitals, health systems, specialty societies, quality collaboratives and health plans. Its platform enables customers to monitor and improve the quality, safety and cost-effectiveness of surgical and other acute and specialty-based care. Led by CEO Brett Furst, the company is based in Ann Arbor, Mich. ArborMetrix closed a Series B financing and intends to use the funds to accelerate national market expansion. The company lists Arboretum Ventures and the Wolverine Venture Fund among its investors, reflecting prior investor relationships.

Total raised

$8M

Funding rounds

2

Latest round

Series B

Latest activity

Feb 2014